Targeted therapies are used in patients with a set gene expression pattern. A targeted therapy that prevents the activation of the estrogen receptor in breast cancer would be beneficial to which type
of patient?

a. patients who express the EGFR receptor in normal cells
b. patients with a mutation that inactivates the estrogen receptor
c. patients that have no estrogen receptor
d. patients with lots of the estrogen receptor expressed in their tumor